June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.See Full Update

Wal-Mart Ties Up With McKesson To Boost Pharmacy Offerings

Published 05/17/2016, 09:03 PM
Updated 07/09/2023, 06:31 AM
AMZN
-
WMT
-
MCK
-
KR
-

Retail giant Wal-Mart Stores Inc. (NYSE:WMT) has been looking to strengthen its health-related business as well as cut costs in its pharmacy operations.

As a part of this initiative, the company has inked a sourcing agreement for generic pharmaceuticals and an expanded long-term distribution agreement with healthcare service company McKesson Corporation (NYSE:MCK) . Under this, the companies will collaborate on sourcing generic pharmaceuticals for their U.S. operations, adding scale and value to both the companies.

Wal-Mart and McKesson have been working together for years in the pharmaceutical category and this latest sourcing agreement strengthens the ties between the companies.

Wal-Mart will benefit from McKesson’s demonstrated strength and expertise in the global pharmaceutical industry. Meanwhile, McKesson will benefit from Wal-Mart’s brand name as well as its commitment to deliver health and wellness services at a low price.

The new agreement is expected to provide Wal-Mart the opportunity to counter the headwinds it has been facing. The company has been facing intense competition on all fronts, ranging from dollar stores to traditional grocery store chains and online business. Its international operations are also under pressure with a stronger dollar affecting sales. At the same time, Wal-Mart projects slower growth in small format Express stores due to price competition from local grocers in some markets.

The Bentonville, AR-based company is facing severe challenges and showing signs of weakness. Wal-Mart expects to incur huge e-commerce expenses. In an effort to compete with the biggest online retailer Amazon.com (NASDAQ:AMZN) and to improve customer service, Wal-Mart is aggressively investing in its e-commerce business. Wal-Mart's focus on e-commerce will in turn lower profit margin, considering shipping costs and price competition.

Wal-Mart is slated to report first-quarter fiscal 2017 results, before the opening bell on May 19. Last quarter, this retail giant posted a positive earnings surprise of 2.05%.

Wal-Mart carries a Zacks Rank #3 (Hold). A better ranked stock in the retail sector is The Kroger Company (NYSE:KR) with a Zacks Rank #2 (Buy).



AMAZON.COM INC (AMZN): Free Stock Analysis Report

WAL-MART STORES (WMT): Free Stock Analysis Report

KROGER CO (KR): Free Stock Analysis Report

MCKESSON CORP (MCK): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.